[HTML][HTML] Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device
J Komen, EY Westerbeek, RW Kolkman, J Roesthuis… - Lab on a Chip, 2020 - pubs.rsc.org
We present a microfluidic device to expose cancer cells to a dynamic, in vivo-like
concentration profile of a drug, and quantify efficacy on-chip. About 30% of cancer patients …
concentration profile of a drug, and quantify efficacy on-chip. About 30% of cancer patients …
Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device
J Komen, EY Westerbeek, RW Kolkman… - Lab on a …, 2020 - research.utwente.nl
We present a microfluidic device to expose cancer cells to a dynamic, in vivo-like
concentration profile of a drug, and quantify efficacy on-chip. About 30% of cancer patients …
concentration profile of a drug, and quantify efficacy on-chip. About 30% of cancer patients …
[引用][C] Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device
J Komen, EY Westerbeek, RW Kolkman, J Roesthuis… - Lab on a Chip, 2020 - cir.nii.ac.jp
Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition
of colorectal cancer cells in a microfluidic device | CiNii Research CiNii 国立情報学研究所 学術 …
of colorectal cancer cells in a microfluidic device | CiNii Research CiNii 国立情報学研究所 学術 …
[PDF][PDF] Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device
J Komen, EY Westerbeek, RW Kolkman, J Roesthuis… - researchgate.net
With the rise of microfluidic cell culture models, including organs-on-chips, there are
opportunities to more realistically mimic in vivo-like concentrations. Our microfluidic device …
opportunities to more realistically mimic in vivo-like concentrations. Our microfluidic device …
Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device
J Komen, EY Westerbeek, RW Kolkman… - Lab on a …, 2020 - pubmed.ncbi.nlm.nih.gov
We present a microfluidic device to expose cancer cells to a dynamic, in vivo-like
concentration profile of a drug, and quantify efficacy on-chip. About 30% of cancer patients …
concentration profile of a drug, and quantify efficacy on-chip. About 30% of cancer patients …
Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device.
J Komen, EY Westerbeek, RW Kolkman… - Lab on a …, 2020 - europepmc.org
We present a microfluidic device to expose cancer cells to a dynamic, in vivo-like
concentration profile of a drug, and quantify efficacy on-chip. About 30% of cancer patients …
concentration profile of a drug, and quantify efficacy on-chip. About 30% of cancer patients …
[PDF][PDF] Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device
J Komen, EY Westerbeek, RW Kolkman, J Roesthuis… - Lab Chip, 2020 - scholar.archive.org
With the rise of microfluidic cell culture models, including organs-on-chips, there are
opportunities to more realistically mimic in vivo-like concentrations. Our microfluidic device …
opportunities to more realistically mimic in vivo-like concentrations. Our microfluidic device …
[PDF][PDF] Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device
J Komen, EY Westerbeek, RW Kolkman, J Roesthuis… - biblio.vub.ac.be
With the rise of microfluidic cell culture models, including organs-on-chips, there are
opportunities to more realistically mimic in vivo-like concentrations. Our microfluidic device …
opportunities to more realistically mimic in vivo-like concentrations. Our microfluidic device …
[PDF][PDF] Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device
J Komen, EY Westerbeek, RW Kolkman, J Roesthuis… - Lab Chip, 2020 - ris.utwente.nl
With the rise of microfluidic cell culture models, including organs-on-chips, there are
opportunities to more realistically mimic in vivo-like concentrations. Our microfluidic device …
opportunities to more realistically mimic in vivo-like concentrations. Our microfluidic device …
[PDF][PDF] Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device
J Komen, EY Westerbeek, RW Kolkman, J Roesthuis… - researchportal.vub.be
With the rise of microfluidic cell culture models, including organs-on-chips, there are
opportunities to more realistically mimic in vivo-like concentrations. Our microfluidic device …
opportunities to more realistically mimic in vivo-like concentrations. Our microfluidic device …